Key facts at a glance
People often encounter the name Angelina Jolie alongside BRCA because of her public decision to pursue preventive surgery in the mid 2010s. To understand that story, it is helpful to separate the person from the genes and the medical options. This overview explains what BRCA1 and BRCA2 are, how variants affect risk, how risk is estimated, and what prevention and monitoring can involve. It does not replace medical advice, but it can help you ask better questions of a genetics professional or primary care team.
- BRCA1 and BRCA2 are DNA repair genes that, when significantly altered, can raise lifetime cancer risks.
- Not all BRCA changes are the same; clinical action depends on the specific variant and personal history.
- Risk estimates combine genetic, family, and lifestyle information rather than relying on a gene result alone.
What BRCA genes do in the body
BRCA1 and BRCA2 are tumor suppressor genes that help fix damage to DNA and keep cells from growing out of control. When these genes have certain harmful variants, the DNA repair system is weakened, which can increase the lifetime risk of some cancers. It is important to note that a BRCA variant is not a diagnosis of cancer; it is an indicator of higher statistical risk that can be managed in different ways. Understanding what the genes do makes it easier to interpret headlines about celebrities and to ask informed questions about screening and prevention.
Inheritance and how variants are passed on
BRCA variants can be inherited from either parent and follow an autosomal dominant pattern. Each child of a person with a BRCA variant has about a 50 percent chance of inheriting that variant. Variants can also arise newly in a person with no family history, although this is less common. Because these genes affect cancer risk, families often see clusters of cancers that prompt genetic testing. Knowing whether a specific variant is present in the family can clarify who in a family may benefit from extra screening or prevention and who may not.
Angelina Jolie’s story and its context
In the mid 2010s, Angelina Jolie wrote publicly about having a preventive double mastectomy and later a preventive salpingo-oophorectomy after testing positive for a BRCA1 variant and considering her family history. At the time, her doctors estimated a significantly elevated lifetime risk compared to the average person, though the exact percentage was not disclosed publicly. Her choices brought attention to how people with high-risk genes can use surgery and careful monitoring to lower cancer risk. While each person’s situation is different, her experience illustrates how genetic results, family history, and personal preferences can interact in real-world decisions.
Variant result nuances that matter
Not every change in BRCA1 or BRCA2 has the same impact. Variants are classified by labs as benign, likely benign, uncertain significance, likely pathogenic, or pathogenic. A pathogenic BRCA variant generally confers increased cancer risk, but the amount of increase varies by gene and specific mutation. A variant of uncertain significance does not confirm increased risk and usually leads to management based on family history. Because reclassification can happen over time, periodic review with a genetics team is common. This underscores the importance of genetic counseling both before and after testing.
Risk, screening, and prevention options today
When a person carries a pathogenic BRCA variant, options often focus on enhanced screening, risk-reducing medications, and risk-reducing surgery. Screening may start earlier and occur more often than for people at average risk, depending on the gene and family history. Medications such as selective estrogen receptor modulators or aromatase inhibitors can sometimes lower risk, though they have side effects. Risk-reducing surgeries, like mastectomy or oophorectomy, can greatly reduce risk but come with their own physical, emotional, and fertility considerations. Decisions are highly personal and depend on age, childbearing plans, overall health, and personal comfort with risk.
| Attribute | Verified detail | Source type |
|---|---|---|
| Genes involved | BRCA1 and BRCA2 | Established hereditary cancer genes |
| Common high-risk variant outcomes | Elevated lifetime risk of breast and ovarian cancers | Population and clinical studies |
| Typical management approaches | Enhanced screening, risk-reducing medications, surgery | Guidelines from oncology and genetics societies |
| Reclassification possibility | Variants can be reclassified over time | Laboratory and clinical practice data |
| Inheritance pattern | d>Autosomal dominant, approximately 50% chance per child | Hereditary cancer genetics references |
How doctors estimate and use risk
Risk in hereditary cancer is never based on a gene result alone. A genetics professional combines the variant result with personal history, such as age at diagnosis, types of cancers, and ancestry, as well as family history across multiple generations. Models like the Tyrer–Cuzick or Claus tables may be used as parts of the estimate, often alongside newer tools tailored for specific genes. Risk estimates help guide when to start screening, whether medications are appropriate, and whether some people might consider prevention more strongly. For many people, especially those without a family history of the relevant cancers, a variant may have low or uncertain impact, while for others it can meaningfully change care.
When genetic counseling is especially helpful
Genetic counseling before testing can clarify goals, insurance and cost issues, and what different results might mean for a person and their family. After testing, counseling can help interpret results in the context of personal and family history and outline concrete next steps. Counselors can also address emotional considerations and family communication, which are important because results can affect relatives. Many cancer centers and telehealth services offer these consultations, and some people work with both a genetic counselor and a medical oncologist to coordinate care.
Practical takeaways for people thinking about testing
If you are thinking about testing because of family history or concerns raised by a celebrity story, it can help to plan ahead. Gather as much family cancer history as possible, including types of cancer and ages at diagnosis, and bring this to a genetics appointment. Ask your provider or a genetics team about the lab they use, how they classify variants, and how results could change over time. Consider what you would do with each type of result, including variants of uncertain significance, and discuss insurance and costs up front. These steps can make the process less overwhelming and ensure that any decision you make is based on the clearest possible information.